๐ Employee Spotlight! ๐ Today, we are excited to highlight our exceptional team member, Regina Dawkins! ๐๏ธ ๐ช๐ต๐ฎ๐ ๐ฎ๐ฟ๐ฒ ๐๐ผ๐บ๐ฒ ๐ธ๐ฒ๐ ๐ณ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐๐ต๐ฎ๐ ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ฒ๐๐๐ถ๐ฐ๐ฎ๐น ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐ป๐ถ๐ฒ๐ ๐๐ต๐ผ๐๐น๐ฑ ๐ฐ๐ผ๐ป๐๐ถ๐ฑ๐ฒ๐ฟ ๐๐ต๐ฒ๐ป ๐ฎ๐๐๐ฒ๐๐๐ถ๐ป๐ด ๐๐ต๐ฒ๐ถ๐ฟ ๐ฐ๐ผ๐บ๐บ๐ฒ๐ฟ๐ฐ๐ถ๐ฎ๐น๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ฟ๐ฒ๐ฎ๐ฑ๐ถ๐ป๐ฒ๐๐ ๐ณ๐ผ๐ฟ ๐๐๐ฟ๐ผ๐ฝ๐ฒ? Understanding the complexity of the European market and local regulatory requirements is crucial, including identification of the necessary import and distribution licenses to successfully launch product within the EU market. Consideration of proposed fiscal supply chains to meet with regulatory expectations for market supply is key in establishing a compliant supply chain. Be aware that Switzerland and the UK whilst physically located in Europe are not EU countries. ๐๏ธ ๐ช๐ต๐ฎ๐ ๐ฎ๐ฟ๐ฒ ๐๐ผ๐บ๐ฒ ๐ฐ๐ผ๐บ๐บ๐ผ๐ป ๐ฐ๐ต๐ฎ๐น๐น๐ฒ๐ป๐ด๐ฒ๐ ๐๐ต๐ฎ๐ ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ฒ๐๐๐ถ๐ฐ๐ฎ๐น ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐ป๐ถ๐ฒ๐ ๐ณ๐ฎ๐ฐ๐ฒ ๐๐ต๐ฒ๐ป ๐ฒ๐ ๐ฝ๐ฎ๐ป๐ฑ๐ถ๐ป๐ด ๐ถ๐ป๐๐ผ ๐๐๐ฟ๐ผ๐ฝ๐ฒ, ๐ฎ๐ป๐ฑ ๐ต๐ผ๐ ๐ฑ๐ผ ๐๐ผ๐ ๐ต๐ฒ๐น๐ฝ ๐๐ต๐ฒ๐บ ๐ผ๐๐ฒ๐ฟ๐ฐ๐ผ๐บ๐ฒ ๐๐ต๐ฒ๐๐ฒ ๐ฐ๐ต๐ฎ๐น๐น๐ฒ๐ป๐ด๐ฒ๐? Understanding the complexity of supplying medicines within European market and the regulatory licences required. With global to local market expertise, PharmaLex can support clients in the navigating complexities of EU, Swiss and UK regulations effectively to enable compliance, minimise risks and support speed to market. We support mapping supply chains and providing local licence expertise and support to successfully obtain local licenses and launch medicinal products within the European market. ๐๏ธ ๐๐ฎ๐ป ๐๐ผ๐ ๐๐ฒ๐น๐น ๐๐ ๐ฎ๐ฏ๐ผ๐๐ ๐ฎ ๐ฝ๐ฟ๐ผ๐ท๐ฒ๐ฐ๐ ๐ผ๐ฟ ๐ถ๐ป๐ถ๐๐ถ๐ฎ๐๐ถ๐๐ฒ ๐๐ผ๐ ๐ต๐ฎ๐๐ฒ ๐ฟ๐ฒ๐ฐ๐ฒ๐ป๐๐น๐ ๐ฏ๐ฒ๐ฒ๐ป ๐ถ๐ป๐๐ผ๐น๐๐ฒ๐ฑ ๐ถ๐ป ๐๐ต๐ฎ๐ ๐๐ผ๐๐ฟ ๐ฝ๐ฎ๐ฟ๐๐ถ๐ฐ๐๐น๐ฎ๐ฟ๐น๐ ๐ฝ๐ฟ๐ผ๐๐ฑ ๐ผ๐ณ? Supporting a US company successfully gain MA approval and launch with the European market by navigating them through the process from MA application, European entity establishment, local licence support, QMS design and development, Qualification of Outsourced activities, staff augmentation, inspection support and successful supply of product to patient. ๐๏ธ ๐ช๐ต๐ฎ๐ ๐ฎ๐ฑ๐๐ถ๐ฐ๐ฒ ๐๐ผ๐๐น๐ฑ ๐๐ผ๐ ๐ด๐ถ๐๐ฒ ๐๐ผ ๐๐ผ๐บ๐ฒ๐ผ๐ป๐ฒ ๐๐ต๐ผ ๐ถ๐ ๐ฐ๐ผ๐ป๐๐ถ๐ฑ๐ฒ๐ฟ๐ถ๐ป๐ด ๐ฎ ๐ฐ๐ฎ๐ฟ๐ฒ๐ฒ๐ฟ ๐ถ๐ป ๐๐ต๐ฒ ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ฒ๐๐๐ถ๐ฐ๐ฎ๐น ๐ถ๐ป๐ฑ๐๐๐๐ฟ๐? A career in the pharmaceutical industry is rewarding, offering development, growth, and job satisfaction while supporting patient safety. Start hands-on in a lab or manufacturing facility to understand processes and systems, enhancing problem-solving skills. Get involved in auditing early to expand your knowledge and expertise, as good auditing skills are invaluable and support an inquisitive mind. ๐ Learn more about our team's work: https://lnkd.in/e_2XZwqt #PharmaLex #TeamSpotlight #PharmaceuticalIndustry #QMC
PharmaLexโs Post
More Relevant Posts
-
Senior Director and Qualified Person at PLX Healthcare Services (Switzerland), a Cencora PharmaLex company
Commercialization readiness is critical, and we see quite often that the Quality Management and Compliance aspects are underestimated by the industry. In addition to the GMP challenges, the GDP and supply chain options can be incredibly complex to put in place... It is wise to secure all these aspects before Product Approval!... Feel free to contact Regina for an initial chat and discuss how we can help you de-risk your product launch!
๐ Employee Spotlight! ๐ Today, we are excited to highlight our exceptional team member, Regina Dawkins! ๐๏ธ ๐ช๐ต๐ฎ๐ ๐ฎ๐ฟ๐ฒ ๐๐ผ๐บ๐ฒ ๐ธ๐ฒ๐ ๐ณ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐๐ต๐ฎ๐ ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ฒ๐๐๐ถ๐ฐ๐ฎ๐น ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐ป๐ถ๐ฒ๐ ๐๐ต๐ผ๐๐น๐ฑ ๐ฐ๐ผ๐ป๐๐ถ๐ฑ๐ฒ๐ฟ ๐๐ต๐ฒ๐ป ๐ฎ๐๐๐ฒ๐๐๐ถ๐ป๐ด ๐๐ต๐ฒ๐ถ๐ฟ ๐ฐ๐ผ๐บ๐บ๐ฒ๐ฟ๐ฐ๐ถ๐ฎ๐น๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ฟ๐ฒ๐ฎ๐ฑ๐ถ๐ป๐ฒ๐๐ ๐ณ๐ผ๐ฟ ๐๐๐ฟ๐ผ๐ฝ๐ฒ? Understanding the complexity of the European market and local regulatory requirements is crucial, including identification of the necessary import and distribution licenses to successfully launch product within the EU market. Consideration of proposed fiscal supply chains to meet with regulatory expectations for market supply is key in establishing a compliant supply chain. Be aware that Switzerland and the UK whilst physically located in Europe are not EU countries. ๐๏ธ ๐ช๐ต๐ฎ๐ ๐ฎ๐ฟ๐ฒ ๐๐ผ๐บ๐ฒ ๐ฐ๐ผ๐บ๐บ๐ผ๐ป ๐ฐ๐ต๐ฎ๐น๐น๐ฒ๐ป๐ด๐ฒ๐ ๐๐ต๐ฎ๐ ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ฒ๐๐๐ถ๐ฐ๐ฎ๐น ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐ป๐ถ๐ฒ๐ ๐ณ๐ฎ๐ฐ๐ฒ ๐๐ต๐ฒ๐ป ๐ฒ๐ ๐ฝ๐ฎ๐ป๐ฑ๐ถ๐ป๐ด ๐ถ๐ป๐๐ผ ๐๐๐ฟ๐ผ๐ฝ๐ฒ, ๐ฎ๐ป๐ฑ ๐ต๐ผ๐ ๐ฑ๐ผ ๐๐ผ๐ ๐ต๐ฒ๐น๐ฝ ๐๐ต๐ฒ๐บ ๐ผ๐๐ฒ๐ฟ๐ฐ๐ผ๐บ๐ฒ ๐๐ต๐ฒ๐๐ฒ ๐ฐ๐ต๐ฎ๐น๐น๐ฒ๐ป๐ด๐ฒ๐? Understanding the complexity of supplying medicines within European market and the regulatory licences required. With global to local market expertise, PharmaLex can support clients in the navigating complexities of EU, Swiss and UK regulations effectively to enable compliance, minimise risks and support speed to market. We support mapping supply chains and providing local licence expertise and support to successfully obtain local licenses and launch medicinal products within the European market. ๐๏ธ ๐๐ฎ๐ป ๐๐ผ๐ ๐๐ฒ๐น๐น ๐๐ ๐ฎ๐ฏ๐ผ๐๐ ๐ฎ ๐ฝ๐ฟ๐ผ๐ท๐ฒ๐ฐ๐ ๐ผ๐ฟ ๐ถ๐ป๐ถ๐๐ถ๐ฎ๐๐ถ๐๐ฒ ๐๐ผ๐ ๐ต๐ฎ๐๐ฒ ๐ฟ๐ฒ๐ฐ๐ฒ๐ป๐๐น๐ ๐ฏ๐ฒ๐ฒ๐ป ๐ถ๐ป๐๐ผ๐น๐๐ฒ๐ฑ ๐ถ๐ป ๐๐ต๐ฎ๐ ๐๐ผ๐๐ฟ ๐ฝ๐ฎ๐ฟ๐๐ถ๐ฐ๐๐น๐ฎ๐ฟ๐น๐ ๐ฝ๐ฟ๐ผ๐๐ฑ ๐ผ๐ณ? Supporting a US company successfully gain MA approval and launch with the European market by navigating them through the process from MA application, European entity establishment, local licence support, QMS design and development, Qualification of Outsourced activities, staff augmentation, inspection support and successful supply of product to patient. ๐๏ธ ๐ช๐ต๐ฎ๐ ๐ฎ๐ฑ๐๐ถ๐ฐ๐ฒ ๐๐ผ๐๐น๐ฑ ๐๐ผ๐ ๐ด๐ถ๐๐ฒ ๐๐ผ ๐๐ผ๐บ๐ฒ๐ผ๐ป๐ฒ ๐๐ต๐ผ ๐ถ๐ ๐ฐ๐ผ๐ป๐๐ถ๐ฑ๐ฒ๐ฟ๐ถ๐ป๐ด ๐ฎ ๐ฐ๐ฎ๐ฟ๐ฒ๐ฒ๐ฟ ๐ถ๐ป ๐๐ต๐ฒ ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ฒ๐๐๐ถ๐ฐ๐ฎ๐น ๐ถ๐ป๐ฑ๐๐๐๐ฟ๐? A career in the pharmaceutical industry is rewarding, offering development, growth, and job satisfaction while supporting patient safety. Start hands-on in a lab or manufacturing facility to understand processes and systems, enhancing problem-solving skills. Get involved in auditing early to expand your knowledge and expertise, as good auditing skills are invaluable and support an inquisitive mind. ๐ Learn more about our team's work: https://lnkd.in/e_2XZwqt #PharmaLex #TeamSpotlight #PharmaceuticalIndustry #QMC
To view or add a comment, sign in
-
๐ Enhance Your Expertise in Regulatory Affairs in the EU! ๐ Are you looking to expand your knowledge and skills in the dynamic field of regulatory affairs within the European Union? Join our cutting edge training program from an industry expert and stay ahead of the curve! ๐ What You'll Gain: ๐ Understanding the procedures for obtaining marketing authorization approval for human pharmaceuticals, along with post-approval obligations. ๐ Practical insights into the latest regulatory updates and trends. ๐ Skills to effectively navigate the regulatory landscape and ensure product compliance. ๐ Examination of proposed changes and regulatory developments affecting pharmaceutical companies in the EU. ๐ Hands-on experience with case studies. Norah Lightowler LLB, BPharm, MR PharmS, FTOPRA, is the owner of Lightowler Associates, regulatory consultants to the pharmaceutical industry offering expert advice and support to pharmaceutical companies in or proposing to enter the European market for human pharmaceuticals. She has wide experience in the pharmaceutical industry including research, as a regulator with the UK regulatory authority and in regulatory affairs as associate director of European regulatory affairs with an international pharmaceutical company. She is experienced in organising and presenting courses on European requirements, procedures, and strategy. Donโt miss this opportunity to stay ahead in your career and ensure your products meet EU regulatory standards. Secure your spot today ๐ https://lnkd.in/geQSFzT5 #pharmaindustry #pharmatraining #pharmaregulatoryaffairs #finConnEurope #pharmalegislation #regulatoryaffairs #regulatorycompliance
To view or add a comment, sign in
-
Guide to Electronic Submissions for Therapeutic Products in Singapore Professionals registering therapeutic products in Singapore must use the HSAโs PRISM system. Key points: New Applicants: Require a CRIS account, accessible via Corppass. Authorization: Companies must authorize individuals for HSA transactions. Submission: Use PRISM for application forms and technical dossier submission. For detailed guidance and links, refer to the PDF provided. #Pharmaceuticals #RegulatoryAffairs #HSA #healthcare #Singapore #lifesciences #regulatoryaffairs #pharma #eu #fda #ectd #regulatoryexcellence #regulatoryintelligence #learning #knowledgesharing Regulatory Affairs Professionals Society (RAPS) #pharmacist #niper
To view or add a comment, sign in
-
Deep Dive into EU-Type IAIN Variations: A Closer Look The pharmaceutical landscape in the European Union is continuously evolving, with Type IAIN variations playing a pivotal role in this dynamic environment. These variations, though considered minor, can have significant implications for drug manufacturers and healthcare professionals alike. Hereโs an expanded view: Change (Variation Request): These are not just minor tweaks but essential updates that ensure our medicines remain effective, safe, and of the highest quality. Whether it's a change in the manufacturing process or the source of an active ingredient, each variation is a step towards innovation and safety. Conditions to be Fulfilled: To navigate these variations successfully, specific conditions must be met. This includes demonstrating that the change does not impact the quality, safety, or efficacy of the product. Rigorous testing and evidence gathering are crucial to fulfill these conditions, ensuring that the product continues to meet all regulatory standards. Documentation to be Supplied: The backbone of any variation application is the documentation. Detailed reports, updated manufacturing protocols, and comprehensive risk assessments form part of the dossier. This documentation must clearly articulate the nature of the change, the rationale behind it, and evidence of compliance with regulatory requirements. Procedure Type: Understanding the procedural pathway is key. For Type IAIN variations, the process is streamlined but requires meticulous attention to detail. The submission is evaluated on a national level, with a clear timeline for regulatory feedback. Timely and accurate submission is crucial to facilitate a smooth review process. If you notice any discrepancies or have additional comments, please donโt hesitate to share your thoughts. Your input is invaluable as we strive for clarity and accuracy in navigating regulatory changes. #PharmaceuticalIndustry #EURegulations #TypeIAIN #RegulatoryExcellence #europe RAPS Europe #healthcareinnovation #eu #eumdr #fda #sfda #nhra #qa #pharmacovigilance #regulatoryexcellence #qms #regulations #regulatorycompliance #pharma #regulatoryintelligence #kaust #knowledgesharing #learning #middleast #pharmaceuticals #drug #apimanufacturing
To view or add a comment, sign in
-
At Celegence, we're a mission-driven force dedicated to revolutionizing #regulatory #compliance in the pharmaceutical, medical device, and IVD industries. Our values are at the core of everything we do: โ Operational, Strategic, and Scientific Expertise: We uniquely blend these elements with cutting-edge technology to empower our clients to achieve regulatory compliance efficiently and cost-effectively. โ Global Presence and Coverage: With a team of educated and experienced consultants, we provide unparalleled quality of service, solving even the most complex regulatory challenges on a global scale. โ Focus on Exceptional Patient Value: Above all, Celegence allows our clients to focus on what truly matters - providing exceptional value to patients around the world. Personally, I bring to Celegence experience in Quality Assurance, particularly in the global production and supply chain management of medicine and food. My contributions to co-authoring and reviewing CMC information, coupled with hands-on experience in internal and third-party audits, have equipped me to navigate regulatory landscapes with precision and expertise. I am thrilled to embark on this journey with Celegence, where I can leverage my experience to further enhance our mission and support our clients in achieving their regulatory goals. Let's connect and explore how Celegence can empower you to excel in regulatory compliance and deliver exceptional patient value. Together, we'll make a meaningful impact in the industry! ๐ก #RegulatoryExcellence #QualityAssurance #CelegenceTeam
To view or add a comment, sign in
-
Time to develop the audit plan for next year? In the pharmaceutical industry, adopting a risk-based approach to the audit plan is imperative. This methodology allows for the identification and prioritization of potential risks across manufacturing, regulatory compliance, and the supply chain. By employing a cross-functional perspective, this approach ensures a comprehensive evaluation, covering critical areas. Effective allocation of audit resources is achieved by concentrating efforts on high-risk areas and suppliers. A key of the risk-based audit approach involves assessing your suppliers' performance over the year. This evaluation considers factors such as deviations, complaints, and audit/inspection outcomes. A robust supplier management system is essential to ensure that suppliers meet the stipulations outlined in quality agreements and comply with regulations. At PharmaRelations we offer comprehensive support throughout the Nordic countries for supplier management and audits. Reach out to us to explore how we can assist you in navigating the complex world of the GxP audit process. Sweden: rosie-marie.holmlund@pharmarelations.se Denmark: camilla.zollner@pharmarelations.dk Norway: ann.kristin.lillelien@pharmarelations.no Finland: jaana.rainesto@pharmarelations.fi #PharmaRelations #GxP #audits #suppliermanagement
To view or add a comment, sign in
-
Curious to hear from smaller U.S. Clinical Pharmaceutical companies on the challenges to commercialize their products into Europe, while continuing with Phase 3 Supply Chain requirements? How does the clinical resources focus on commercialization activities, such as: Regulatory Submission, Distribution and Logistics Network Buildout, Customer Service, Order 2 Cash, onboarding new Transportation and Distribution partners, Tax Strategies, Supply Chain and Operations Support, Are you using the same resources running the clinical supplies and operations? NOW, how great would it be to rely on outsourced expertise, such as Professional Supply Chain Resources and their team of experts to completely build out your commercial supply chain footprint in Europe, bring in the right EU partners, and manage the Supply chain with continued support and operational management? Call or Text us today. hashtag #teamwork #pharmaceuticalindustry #globallogistics #supplychainmanagement
To view or add a comment, sign in
-
News from PCC Canada 2024! ๐ฉโ๏ธ We're excited to be attending the Pharmaceutical Compliance Congress at the The Omni King Edward Hotel in Toronto! This event is as important gathering for pharmaceutical and MedTech professionals, aimed at optimizing compliance operations, fostering stakeholder collaboration, navigating regulatory/code updates, and addressing emerging risk areas through peer collaboration across the healthcare landscape. At DiliTrust, we understand the complexities and challenges faced by the pharmaceutical and MedTech industries. With over 20 years of experience working with legal and pharmaceutical professionals, we've developed solutions that meet the highest compliance standards. Our expertise in regulatory compliance is unparalleled. Regulatory bodies worldwide enforce stringent rules for effective Pharmacovigilance (PV) through Safety Data Exchange Agreements (SDEAs). Our Contract Lifecycle Management (CLM) solution is specifically tailored to manage SDEAs, ensuring your legal teams can navigate these complexities with ease. ๐ Don't Miss Out! ๐ Weโve created a comprehensive guide to help legal teams optimize their CLM for better SDEA management. This guide is designed to enhance your understanding and implementation of best practices in compliance. โก๏ธ https://lnkd.in/exWpjJvS Come visit us at PCC Canada 2024 and discover how DiliTrust can help you streamline your compliance operations and ensure regulatory adherence. Rabih Atmih Anshoo Govil Maxime Delagneau Karen Gastle Alexandre Peron Matthieu Motillon #PCCCanada2024 #PharmaceuticalCompliance #MedTech #ComplianceExcellence #DiliTrust #ContractLifecycleManagement #Pharmacovigilance #SDEA #RegulatoryCompliance #HealthcareInnovation #Toronto
To view or add a comment, sign in
-
In need of regulatory support?
Regulatory Affairs | Life Science Consultants | Outsourcing | PharmaRelations Nordic Talent Services for Life Science
Regulatory Affairs for the Nordic Region! Navigating the Nordic regulatory landscape requires an in-depth understanding of country-specific regulations. Although Nordic health authorities cooperate closely, they still have their own national legislation and processes for approving pharmaceutical products on the market. At PharmaRelations, our dedicated professionals are committed to tackling critical regulatory issues, offering strategic advice, and providing the flexibility, you need. We take pride in our team of local experts who also specialize in tasks such as variations, product information, translation/QC checks, catalog text updates, and artwork. With PharmaRelations, you're not just getting regulatory support; you're gaining a partner that understands the nuances of the Nordic market. Our tailored solutions ensure compliance and efficiency, which enables you to stay focused on your core business operations. Connect with us to learn more about how we can streamline your regulatory processes and help you succeed in the Nordic market. #regulatoryaffairs #nordicmarket #lifesciences #consulting Ann Kristin Lillelien, Jaana Rainesto, Anna Karin Sverdrup
To view or add a comment, sign in
-
500K+ Imp, 13K+ followers | Regulatory Affairs Manager | Expert in US #Labeling Compliance | Formerly worked with Sun Pharma, L&T, Endo, and Amneal Pharma
๐กWhat role does ICH play in the field of Regulatory Affairs?๐ญ๐ As a passionate professional in the Regulatory Affairs field, I am continually amazed by the collaborative efforts that shape the landscape of pharmaceutical development and market access worldwide. Today, I want to shed light on the pivotal role of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) in shaping regulated markets and ensuring the safety and efficacy of pharmaceutical products across borders. ๐๐ ๐ค Harmonizing Regulatory Standards: The ICH brings together regulatory authorities and the pharmaceutical industry from different regions to develop harmonized guidelines and standards. This harmonization is crucial in fostering global consistency and reducing redundancies in regulatory processes, streamlining the journey from research to patient access. ๐ก ๐ Global Reach: Through its collaborative initiatives, the ICH has achieved widespread acceptance of its guidelines in various regulated markets across the globe. Notably, major markets such as the United States (FDA), the European Union (EMA), Japan (PMDA), Canada (Health Canada), Switzerland, Australia (TGA), South Korea (MFDS), and Brazil (ANVISA) have embraced ICH guidelines. ๐โจ ๐ Enhanced Efficiency: The adoption of ICH guidelines has significantly enhanced the efficiency of drug development and regulatory approvals. By adhering to standardized guidelines, pharmaceutical companies can navigate regulatory requirements more effectively, accelerating the availability of safe and effective medicines to patients in need. ๐๐ ๐งช Ensuring Patient Safety: One of the core principles of ICH is ensuring the safety and well-being of patients. By implementing uniform quality standards, best practices, and risk-based approaches, the ICH guidelines promote the development of high-quality pharmaceutical products that undergo rigorous evaluation before reaching patients. ๐ฉบโค๏ธ ๐ Innovation and Collaboration: ICH fosters a spirit of innovation and collaboration between regulatory authorities and the pharmaceutical industry. This partnership creates an environment where cutting-edge technologies, novel therapies, and groundbreaking treatments can be developed and brought to the market more efficiently and responsibly. ๐ค๐ก As a Regulatory Affairs professional, I am committed to staying updated with the latest developments in ICH guidelines. This knowledge empowers me to navigate the dynamic regulatory landscape confidently and contribute to the development of safe and effective medicines for patients globally. ๐๐ช Together, we can ensure that patients worldwide have access to innovative and life-changing therapies๐ #RegulatoryAffairs #ICH #PharmaceuticalDevelopment #GlobalStandards #PatientSafety #Collaboration #Innovation #Harmonization #LinkedInPost #HealthcareIndustry
To view or add a comment, sign in
95,612 followers